Clinical Trial Update: Observational Study of Obstructive Lung Disease (NOVELTY)

View source ↗

Summary

A completed observational study on obstructive lung disease (NOVELTY) sponsored by AstraZeneca, evaluating asthma and chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, COPD | Status: COMPLETED